Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FULC
FechaHoraFuenteTítuloSímboloCompañía
18/06/202415:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
17/06/202415:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
13/05/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
08/03/202417:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202416:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202416:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FULCFulcrum Therapeutics Inc
27/02/202415:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FULCFulcrum Therapeutics Inc
22/08/202306:48Dow Jones NewsFulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study HoldNASDAQ:FULCFulcrum Therapeutics Inc
11/08/202315:53GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
03/07/202315:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
29/06/202315:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
26/06/202305:01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FULCFulcrum Therapeutics Inc
23/06/202304:45PR Newswire (US)FULC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulcrum Shareholders of a Lead Plaintiff Deadline of June 27, 2023NASDAQ:FULCFulcrum Therapeutics Inc
21/06/202304:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2023 - (NASDAQ: FULC)NASDAQ:FULCFulcrum Therapeutics Inc
20/06/202306:00GlobeNewswire Inc.Advocacy and Industry Partners Launch New Global Coalition to Speed Delivery of New Therapies for Facioscapulohumeral Muscular Dystrophy (FSHD)NASDAQ:FULCFulcrum Therapeutics Inc
09/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FULCFulcrum Therapeutics Inc
15/05/202306:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FULCFulcrum Therapeutics Inc
28/04/202315:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FULCFulcrum Therapeutics Inc
28/04/202315:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FULCFulcrum Therapeutics Inc
09/03/202307:28Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FULCFulcrum Therapeutics Inc
06/03/202315:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FULCFulcrum Therapeutics Inc
24/02/202307:56Dow Jones NewsFulcrum Therapeutics Shares Plummet as FDA Puts Sickle-Cell Study on HoldNASDAQ:FULCFulcrum Therapeutics Inc
14/02/202315:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FULCFulcrum Therapeutics Inc
17/01/202322:15GlobeNewswire Inc.Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common StockNASDAQ:FULCFulcrum Therapeutics Inc
17/01/202315:01GlobeNewswire Inc.Fulcrum Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:FULCFulcrum Therapeutics Inc
04/01/202306:02GlobeNewswire Inc.Fulcrum Therapeutics Provides Business Update and 2023 OutlookNASDAQ:FULCFulcrum Therapeutics Inc
04/01/202306:01GlobeNewswire Inc.Fulcrum Therapeutics Announces CEO TransitionNASDAQ:FULCFulcrum Therapeutics Inc
01/12/202215:01GlobeNewswire Inc.Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap ConferenceNASDAQ:FULCFulcrum Therapeutics Inc
15/11/202218:11TipRanksFULC, CMBM: 2 Underdog Stocks That Deserve Attention Right NowNASDAQ:FULCFulcrum Therapeutics Inc
14/11/202210:35TipRanksMorgan Stanley Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC)NASDAQ:FULCFulcrum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FULC